Table 5.
Model | Variables | Men | Women | ||
---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | ||
Model 1 | FIB | 1.491 (0.980–2.269) | 0.062 | 3.206 (1.625–6.326) | 0.001 |
FIB tertiles | |||||
Tertile 1 | 1 | 1 | |||
Tertile 2 | 0.672 (0.339–1.331) | 0.255 | 2.555 (0.800–8.159) | 0.113 | |
Tertile 3 | 1.226 (0.627–2.399) | 0.551 | 8.337 (2.723–25.521) | < 0.001 | |
Model 2 | FIB | 1.416 (0.854–2.347) | 0.178 | 2.557 (1.164–5.617) | 0.019 |
FIB tertiles | |||||
Tertile 1 | 1 | 1 | |||
Tertile 2 | 0.626 (0.304–1.288) | 0.203 | 2.386 (0.723–7.878) | 0.153 | |
Tertile 3 | 0.986 (0.463–2.101) | 0.970 | 5.823 (1.696–19.994) | 0.005 | |
Model 3 | FIB | 1.416 (0.843–2.369) | 0.189 | 3.677 (1.539–8.785) | 0.003 |
FIB tertiles | |||||
Tertile 1 | 1 | 1 | |||
Tertile 2 | 0.654 (0.312–1.370) | 0.260 | 2.885 (0.797–10.439) | 0.106 | |
Tertile 3 | 1.004 (0.465–2.169) | 0.992 | 8.531 (2.153–33.802) | 0.002 |
Model 1 unadjusted
Model 2 adjusted for dyslipidemia, hsCRP (P < 0.05 in univariate analysis)
Model 3 adjusted for dyslipidemia, diabetes, statins, beta-blocker and hsCRP (P < 0.1 in univariate analysis)